Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study.
作者信息
Agosti Pasquale, Kouraki Afroditi, Dionisi Tommaso, Addolorato Giovanni, D'Innocenzo Luca, Sorrentino Silvia, De Maio Flavio, De Candia Erica, Blanco-Miguez Aitor, Bazzani Davide, Bonadiman Angela, Tonidandel Guendalina, Bolzan Mattia, Gianniello Francesca, Passamonti Serena M, Abbattista Maria, Valdes Ana M, Bucciarelli Paolo, Peyvandi Flora, Menni Cristina
机构信息
Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Italy (P.A., F.P., C.M.).
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy (P.A., F.G., S.M.P., M.A., P.B., F.P.).
出版信息
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2659-2661. doi: 10.1161/ATVBAHA.124.321490. Epub 2024 Oct 31.
Abstract
摘要
相似文献
1
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study.华法林治疗患者的肠道微生物群多样性和组成与治疗范围内的时间相关：一项初步研究。
Arterioscler Thromb Vasc Biol. 2024 Dec;44(12):2659-2661. doi: 10.1161/ATVBAHA.124.321490. Epub 2024 Oct 31.
2
Vitamin A carotenoids, but not retinoids, mediate the impact of a healthy diet on gut microbial diversity.维生素A类胡萝卜素而非视黄醇介导健康饮食对肠道微生物多样性的影响。
BMC Med. 2024 Aug 7;22(1):321. doi: 10.1186/s12916-024-03543-4.
3
Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.维生素K拮抗剂的比较药代动力学：华法林、苯丙香豆素和醋硝香豆素。
Clin Pharmacokinet. 2005;44(12):1227-46. doi: 10.2165/00003088-200544120-00003.
4
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?华法林还是醋硝香豆素：哪种在口服抗凝剂管理中更优？
Thromb Haemost. 1998 Dec;80(6):899-902.
5
Exploring the complex relationship between vitamin K, gut microbiota, and warfarin variability in cardiac surgery patients.探讨心脏手术患者中维生素 K、肠道菌群和华法林变异性之间的复杂关系。
Int J Surg. 2023 Dec 1;109(12):3861-3871. doi: 10.1097/JS9.0000000000000673.
6
[The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].[醋硝香豆素与华法林治疗下肢深静脉血栓形成患者的疗效及安全性]
Orv Hetil. 2012 May 20;153(20):786-90. doi: 10.1556/OH.2012.29350.
7
The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.三种维生素K拮抗剂（醋硝香豆素、华法林和苯丙香豆素）维持剂量之间的关系。
Thromb Res. 2008;123(2):225-30. doi: 10.1016/j.thromres.2008.01.020. Epub 2008 Apr 14.
8
The microbial metagenome and bone tissue composition in mice with microbiome-induced reductions in bone strength.微生物群导致骨强度降低的小鼠的微生物宏基因组和骨组织组成
Bone. 2019 Oct;127:146-154. doi: 10.1016/j.bone.2019.06.010. Epub 2019 Jun 14.
9
[Anticoagulant efficacy of different pharmacological presentations of vitamin K antagonists].[维生素K拮抗剂不同剂型的抗凝疗效]
Rev Med Chil. 2020 Sep;148(9):1254-1260. doi: 10.4067/S0034-98872020000901254.
10
Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study).在基层医疗中使用醋硝香豆素或华法林进行非瓣膜性心房颤动的抗凝控制（Fantas-TIC研究）。
Int J Environ Res Public Health. 2021 May 26;18(11):5700. doi: 10.3390/ijerph18115700.
引用本文的文献
1
A perspective on thrombogenesis through gut microbiota-derived bile acids and platelet activation.通过肠道微生物群衍生的胆汁酸和血小板活化对血栓形成的一种见解。
Nat Cardiovasc Res. 2025 May;4(5):505-507. doi: 10.1038/s44161-025-00634-0.
本文引用的文献
1
The gut microbiota in experimental abdominal aortic aneurysm.实验性腹主动脉瘤中的肠道微生物群
Front Cardiovasc Med. 2023 Feb 22;10:1051648. doi: 10.3389/fcvm.2023.1051648. eCollection 2023.
2
Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4.利用 MetaPhlAn 4 对未鉴定物种进行宏基因组分类分析的扩展和改进。
Nat Biotechnol. 2023 Nov;41(11):1633-1644. doi: 10.1038/s41587-023-01688-w. Epub 2023 Feb 23.
3
Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications.肠道微生物群与维生素K拮抗剂使用者口服抗凝治疗的质量：潜在影响综述
J Clin Med. 2021 Feb 11;10(4):715. doi: 10.3390/jcm10040715.
4
Gut Microbiome Associates With Lifetime Cardiovascular Disease Risk Profile Among Bogalusa Heart Study Participants.在博加卢萨心脏研究参与者中，肠道微生物群与终生心血管疾病风险状况相关。
Circ Res. 2016 Sep 30;119(8):956-64. doi: 10.1161/CIRCRESAHA.116.309219. Epub 2016 Aug 9.
5
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.口服抗凝治疗：抗血栓治疗和血栓预防，第 9 版：美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e44S-e88S. doi: 10.1378/chest.11-2292.
Zotero 插件